Galantamine added to antipsychotic treatment in chronic schizophrenia:: Cognitive improvement?

被引:13
|
作者
Noren, U. [1 ]
Bjorner, A. [1 ]
Sonesson, O. [1 ]
Eriksson, L. [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Hosp, Unit Clin Trials, S-42250 Gothenburg, Sweden
关键词
D O I
10.1016/j.schres.2006.03.039
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:302 / 304
页数:3
相关论文
共 50 条
  • [1] Cognitive function and antipsychotic treatment in chronic schizophrenia
    Kalwa, A.
    Rzewuska, M.
    Borkowska, A.
    Pirog-Balcerzak, A.
    Luks, M.
    Skalska, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S407 - S408
  • [2] Short-term improvement by minocycline added to olanzapine antipsychotic treatment in schizophrenia
    Hallak, J.
    Chaves, C.
    Marque, C.
    Crippa, J.
    Chaudhry, I.
    Husain, N.
    Wichert-Ana, L.
    Deakin, J.
    Zuardi, A.
    Dursun, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S538 - S539
  • [3] Galantamine for the treatment of cognitive impairments in people with schizophrenia
    Buchanan, Robert W.
    Conley, Robert R.
    Dickinson, Dwight
    Ball, M. Patricia
    Feldman, Stephanie
    Gold, James M.
    McMahon, Robert P.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (01): : 82 - 89
  • [4] Galantamine for the treatment of cognitive impairments in patients with schizophrenia
    Buchanan, Robert W.
    Conley, Robert C.
    Dickinson, Dwight
    Nelson, Matthew W.
    Gold, James M.
    Mcmahon, Robert P.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S245 - S245
  • [5] Galantamine for the treatment of cognitive impairments in patients with schizophrenia
    Buchanan, R. W.
    Conley, R. C.
    Dickinson, D.
    Nelson, M. W.
    Gold, J. M.
    McMahon, R. P.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 424 - 424
  • [6] Cognitive improvement in schizophrenia with novel antipsychotic medications
    Purdon, SE
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 35 : S51 - S60
  • [7] SHORT-TERM IMPROVEMENT BY MINOCYCLINE ADDED TO OLANZAPINE ANTIPSYCHOTIC TREATMENT IN PARANOID SCHIZOPHRENIA
    Chaves, Cristiano
    Marque, C. R.
    Chaudhry, I. B.
    Husain, N.
    Minhas, F.
    Oliveira, J. P.
    Wichert-Ana, L.
    Kato, M.
    Dursun, S.
    Richardson, P.
    Stirling, J.
    Deakin, J. F.
    Zuardi, A. W.
    Hallak, J. E.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 354 - 355
  • [8] Cognitive improvement in schizophrenia and schizoaffective disorder by augmentation of risperidone with galantamine
    Schubert, MH
    Young, KA
    Justice, SB
    Durgam, SK
    Schmitz, WM
    House, MD
    Hicks, PB
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 503 - 503
  • [9] Cognitive improvement in response to antipsychotic drugs - Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
    Heinrichs, R. Walter
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (06) : 631 - 632
  • [10] The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia
    Friedman, JI
    Ocampo, R
    Elbaz, Z
    Parrella, M
    White, L
    Bowler, S
    Davis, KL
    Harvey, PD
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (03) : 237 - 242